Antithrombotic Therapy in Patients With Polyvascular Disease: Practice Your Skills
Upon completion of this activity, participants will:
- Demonstrate improved performance associated with:
- Assessing risk for cardiovascular events among patients with chronic cardiovascular disease
- Tailoring antithrombotic therapy to reduce the risk for CV events and optimize outcomes.
- Using effective monitoring and follow-up strategies to optimize the success of antithrombotic therapy
Keith A. A. Fox, MD, MBChB, FRCP, FESC, FMedSci
University of Edinburgh
Edinburgh, United Kingdom
Kelley Robert Branch, MD, MS
University of Washington
Seattle, Washington, United States
Steering Committee Member
George L. Bakris, MD
Professor of Medicine
AHA Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, Illinois, United States
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 1.0 contact hours are in the area of pharmacology.